DK

Debasish Kumar Ghosh

Active Director Director DIN 10967080
DIN 10967080 First appointment Feb 2025 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Debasish Kumar Ghosh

Data last updated:

Debasish Kumar Ghosh is a Director at Accelgen Bharat Bioinnovations Private Limited (since 2025). The company operates in Professional Services.

DIN 10967080
Primary Designation Director
Industry Professional Services
First Appointment 24 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Feb 20252025Active

Board colleagues of Debasish Kumar Ghosh

NameDINCompanyDesignation
Anirban Mandal10967081Accelgen Bharat Bioinnovations Private LimitedDirector

Directorship timeline

Open interactive timeline →
Accelgen Bharat Bioinnovations Private Limited
Premium access

Shareholding and investment profile for Debasish Kumar Ghosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Debasish Kumar Ghosh

Debasish Kumar Ghosh currently holds 1 directorship: Accelgen Bharat Bioinnovations Private Limited (Director, since 24 Feb 2025).

Debasish Kumar Ghosh was first appointed on 24 Feb 2025 as Director at Accelgen Bharat Bioinnovations Private Limited.

The current boards of Debasish Kumar Ghosh's companies include Anirban Mandal (Accelgen Bharat Bioinnovations Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available